Clinical trial
Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic…
NCT00219882 · Ramsey, Bonnie, MD, Other · Completed
Key facts
| NCT number | NCT00219882 |
|---|---|
| Title | Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis |
| Official title | A Phase I Safety and Dose Finding Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis Who Are Homozygous for Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (ΔF508 CFTR) Mutation |
| Acronym | SEER |
| Lead sponsor | Ramsey, Bonnie, MD, Other |
| Collaborators | Seer Pharmaceuticals Industry CF Therapeutics Development Network Coordinating Center Cystic Fibrosis Foundation |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | standardized turmeric root extract |
| Enrollment | 11 |
| Start date | Apr 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: